SCHEMBL27098963

SCHEMBL27098963

Cc1cc2c(cn1)c1ccc(Br)cc1n2C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.37
PDGFRA P16234 1/20 0.35
CDK5 Q00535 1/20 0.35
TYRO3 Q06418 1/20 0.35
ACHE P22303 2/20 0.35
EGLN1 Q9GZT9 2/20 0.35
CASP3 P42574 1/20 0.34
MAPT P10636 2/20 0.33
TSHR P16473 2/20 0.33
MAOA P21397 1/20 0.33
DYRK1A Q13627 1/20 0.33
PTGES O14684 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
ALOX15 P16050 1/20 0.33
MAPK1 P28482 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
AXL P30530 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29556288 0.82 GPR3 (0.44) HSD17B10PDGFRACDK5TYRO3ACHE
SCHEMBL3281839 0.82 GPR3 (0.44) HSD17B10PDGFRACDK5TYRO3ACHE
SCHEMBL13100683 0.79 GPR3 (0.57) HSD17B10ACHEMAPTNPC1ALDH1A1
SCHEMBL5014769 0.78 ACHE (0.41) HSD17B10PDGFRACDK5TYRO3ACHE
SCHEMBL22906722 0.78 NPC1 (0.44) MAPTNPC1RAB9A
SCHEMBL13374193 0.77 ALDH1A1 (0.41) PDGFRACDK5TYRO3ACHEEGLN1
SCHEMBL16942957 0.77 TOP2A (0.42) HSD17B10PDGFRACDK5TYRO3ACHE
SCHEMBL27097220 0.73 PRMT5 (0.41) MAPTNPC1RAB9ACYP2A6
SCHEMBL8011931 0.73 GPR3 (0.64) HSD17B10ACHEMAPTTSHRNPC1
SCHEMBL28032383 0.72 ALDH1A1 (0.45) HSD17B10PDGFRACDK5TYRO3ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912699-B2 Tau-protein targeting compounds and associated ARVINAS OPERATIONS, INC. (US) 2024-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11912699-B2 Tau-protein targeting compounds and associated MAPT, VHL, CRBN HSD17B10 3747/4885PDGFRA 3283/4885CDK5 150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.